AU6878400A - Nitroimidazole derivative and diagnostic imaging agent containing the same - Google Patents
Nitroimidazole derivative and diagnostic imaging agent containing the sameInfo
- Publication number
- AU6878400A AU6878400A AU68784/00A AU6878400A AU6878400A AU 6878400 A AU6878400 A AU 6878400A AU 68784/00 A AU68784/00 A AU 68784/00A AU 6878400 A AU6878400 A AU 6878400A AU 6878400 A AU6878400 A AU 6878400A
- Authority
- AU
- Australia
- Prior art keywords
- derivative
- agent containing
- imaging agent
- diagnostic imaging
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002059 diagnostic imaging Methods 0.000 title abstract 2
- 239000012216 imaging agent Substances 0.000 title abstract 2
- 150000004957 nitroimidazoles Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 238000003384 imaging method Methods 0.000 abstract 2
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- High Energy & Nuclear Physics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Hydrogenated Pyridines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11/259057 | 1999-09-13 | ||
| JP25905799 | 1999-09-13 | ||
| JP11/260315 | 1999-09-14 | ||
| JP26031599 | 1999-09-14 | ||
| PCT/JP2000/006226 WO2001019799A2 (en) | 1999-09-13 | 2000-09-12 | Nitroimidazole derivative and diagnostic imaging agent containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6878400A true AU6878400A (en) | 2001-04-17 |
Family
ID=26543940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU68784/00A Abandoned AU6878400A (en) | 1999-09-13 | 2000-09-12 | Nitroimidazole derivative and diagnostic imaging agent containing the same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6743925B1 (https=) |
| EP (1) | EP1218351B1 (https=) |
| JP (1) | JP4116793B2 (https=) |
| KR (1) | KR100708822B1 (https=) |
| AT (1) | ATE293607T1 (https=) |
| AU (1) | AU6878400A (https=) |
| CA (1) | CA2384879C (https=) |
| DE (1) | DE60019622T2 (https=) |
| ES (1) | ES2237447T3 (https=) |
| WO (1) | WO2001019799A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2841554B1 (fr) * | 2002-07-01 | 2008-01-18 | Commissariat Energie Atomique | Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules |
| US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
| US9017724B2 (en) | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
| WO2008090731A1 (ja) * | 2007-01-23 | 2008-07-31 | Pola Pharma Inc. | ２－ニトロイミダゾール誘導体の製造法 |
| CA2978149C (en) | 2008-03-21 | 2019-02-12 | The General Hospital Corporation | Inositol derivatives for the detection and treatment of alzheimer's disease and related disorders |
| JP2012532879A (ja) * | 2009-07-07 | 2012-12-20 | ノームオキシーズ，インコーポレイテッド | イノシトールトリピロリン酸を使用して多剤耐性を低減する方法 |
| US20120219500A1 (en) | 2009-10-26 | 2012-08-30 | Fujifilm Ri Pharma Co., Ltd. | Diagnostic agent for infectious diseases |
| NL1038473C2 (en) * | 2010-12-24 | 2012-06-27 | Centre Nat Rech Scient | Cancer targeting using carbonic anhydrase isoform ix inhibitors. |
| ES2569196T3 (es) * | 2011-09-22 | 2016-05-09 | ihon Medi-Physics Co., Ltd. | Compuesto marcado con flúor radiactivo |
| CA2959776A1 (en) * | 2014-09-25 | 2016-03-31 | Nihon Medi-Physics Co., Ltd. | Renal imaging agent |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0819111B2 (ja) * | 1987-10-22 | 1996-02-28 | ポーラ化成工業株式会社 | ２―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤 |
| EP0669913B1 (en) * | 1992-11-19 | 2003-03-05 | The Trustees Of The University Of Pennsylvania | Detection of hypoxia |
| WO1995009844A1 (en) | 1993-10-04 | 1995-04-13 | Board Of Regents, The University Of Texas System | Rapid synthesis and use of 18f-fluoromisonidazole and analogs |
-
2000
- 2000-09-12 AT AT00957119T patent/ATE293607T1/de active
- 2000-09-12 US US10/070,899 patent/US6743925B1/en not_active Expired - Lifetime
- 2000-09-12 AU AU68784/00A patent/AU6878400A/en not_active Abandoned
- 2000-09-12 JP JP2001523379A patent/JP4116793B2/ja not_active Expired - Lifetime
- 2000-09-12 KR KR1020027002927A patent/KR100708822B1/ko not_active Expired - Lifetime
- 2000-09-12 CA CA2384879A patent/CA2384879C/en not_active Expired - Fee Related
- 2000-09-12 EP EP00957119A patent/EP1218351B1/en not_active Expired - Lifetime
- 2000-09-12 ES ES00957119T patent/ES2237447T3/es not_active Expired - Lifetime
- 2000-09-12 DE DE60019622T patent/DE60019622T2/de not_active Expired - Lifetime
- 2000-09-12 WO PCT/JP2000/006226 patent/WO2001019799A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60019622T2 (de) | 2006-03-02 |
| WO2001019799A3 (en) | 2002-05-10 |
| ES2237447T3 (es) | 2005-08-01 |
| WO2001019799A2 (en) | 2001-03-22 |
| JP4116793B2 (ja) | 2008-07-09 |
| ATE293607T1 (de) | 2005-05-15 |
| CA2384879C (en) | 2010-11-30 |
| EP1218351B1 (en) | 2005-04-20 |
| US6743925B1 (en) | 2004-06-01 |
| JP2003509413A (ja) | 2003-03-11 |
| DE60019622D1 (de) | 2005-05-25 |
| KR20020057955A (ko) | 2002-07-12 |
| KR100708822B1 (ko) | 2007-04-17 |
| CA2384879A1 (en) | 2001-03-22 |
| EP1218351A2 (en) | 2002-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4798000A (en) | Triarylimidazoles | |
| DE3574137D1 (en) | Pyridazinones, their preparation and use, medicaments containing pyridazinones | |
| CA2281545A1 (en) | N-heterocyclic derivatives as nos inhibitors | |
| AU553338B2 (en) | Redox indicators | |
| AU6878400A (en) | Nitroimidazole derivative and diagnostic imaging agent containing the same | |
| DE60005502D1 (de) | 4'-c-ethynyl-purin-nukleoside | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| NO941977D0 (no) | Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav | |
| CA2196900A1 (en) | Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells | |
| EP0786252A4 (en) | ANTITUARY AGENTS | |
| CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds | |
| EP0757987A4 (en) | PYRAZOLECARBOXYLIC ACID DERIVATIVE AND PLANT DISEASE CONTROL AGENT | |
| CA2112690A1 (en) | Amino acid derivative | |
| HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
| CA2231118A1 (en) | Pharmaceutical preparation containing nimesulide for topical use | |
| DE3668888D1 (de) | Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung. | |
| AU5731386A (en) | 99mTc(III) myocardial imaging agents which are non-reducable in vivo | |
| UA66832C2 (uk) | Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція | |
| PT1189908E (pt) | Alcaloides de indolocarbazole de um actinomiceto marinho | |
| AU8145891A (en) | Acid addition salts of optically active alaninanilide compounds and pharmaceutical compositions containing the same | |
| IE780526L (en) | Compositions for inhibiting male fertility | |
| AU7587596A (en) | Antifungal substances be-49385 and process for producing the same | |
| CA2276875A1 (en) | Insecticidal oxadiazine compounds | |
| CA2207443A1 (en) | Tricyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |